Literature DB >> 22162484

The impact of reflux burden on Pseudomonas positivity in children with cystic fibrosis.

Kara Palm1, Gregory Sawicki, Rachel Rosen.   

Abstract

OBJECTIVES: Nonacid gastroesophageal reflux (GER), particularly in patients taking acid suppression, has been implicated as a cause of respiratory infections. We hypothesize that children with cystic fibrosis (CF) and a higher nonacid reflux burden have greater rates of Pseudomonas aeruginosa (Pa) infection than patients with a lower reflux burden. STUDY
DESIGN: We reviewed the multichannel intraluminal impedance (pH-MII) tracings of 35 patients with CF between 2003 and 2010. We compared the reflux profiles between those patients who were Pa positive and Pa negative.
RESULTS: The mean age was 13.5 ± 5.8 years. Twenty-seven patients (76%) were Pa positive. Ninety seven percent of patients were taking proton pump inhibitors during pH-MII testing. The mean percentage of time pH was <4 was 8.5 ± 12%. Pa patients had a significantly higher total, acid and proximal nonacid reflux burden (P < 0.009). There was a negative correlation between nonacid reflux burden and FEV1 (r = -0.397, P = 0.03) and between total number of reflux events and FEV1 (r = -0.474, P = 0.009). After adjusting for age and FEV1, total reflux burden remains significantly associated with Pa positivity (P = 0.055).
CONCLUSIONS: Increased reflux burden may predispose patients to Pa infection and worse lung function.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22162484     DOI: 10.1002/ppul.21598

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  17 in total

1.  16S community profiling identifies proton pump inhibitor related differences in gastric, lung, and oropharyngeal microflora.

Authors:  Rachel Rosen; Lan Hu; Janine Amirault; Umakanth Khatwa; Doyle V Ward; Andrew Onderdonk
Journal:  J Pediatr       Date:  2015-02-04       Impact factor: 4.406

Review 2.  Azithromycin use in patients with cystic fibrosis.

Authors:  N Principi; F Blasi; S Esposito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-17       Impact factor: 3.267

3.  Changes in gastric and lung microflora with acid suppression: acid suppression and bacterial growth.

Authors:  Rachel Rosen; Janine Amirault; Hongye Liu; Paul Mitchell; Lan Hu; Umakanth Khatwa; Andrew Onderdonk
Journal:  JAMA Pediatr       Date:  2014-10       Impact factor: 16.193

4.  Aspiration Pneumonia: a Shadow in Post-Bariatric Patient : Correlation between aspiration and minigrastric bypass.

Authors:  Roberto Cuomo; Francesco Ruben Giardino; Giuseppe Nisi; Cesare Brandi; Irene Zerini; Costantino Voglino; Ilaria Gaggelli; Luca Grimaldi
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

5.  Bile acids repress hypoxia-inducible factor 1 signaling and modulate the airway immune response.

Authors:  Claire Legendre; F Jerry Reen; David F Woods; Marlies J Mooij; Claire Adams; Fergal O'Gara
Journal:  Infect Immun       Date:  2014-06-09       Impact factor: 3.441

Review 6.  Pregnancy and cystic fibrosis: Approach to contemporary management.

Authors:  James Geake; George Tay; Leonie Callaway; Scott C Bell
Journal:  Obstet Med       Date:  2014-11-07

7.  Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Authors:  Rachel Rosen; Yvan Vandenplas; Maartje Singendonk; Michael Cabana; Carlo DiLorenzo; Frederic Gottrand; Sandeep Gupta; Miranda Langendam; Annamaria Staiano; Nikhil Thapar; Neelesh Tipnis; Merit Tabbers
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-03       Impact factor: 2.839

8.  Gastroesophageal reflux in cystic fibrosis across the age spectrum.

Authors:  Frederick W Woodley; Don Hayes; Benjamin T Kopp; Melissa Moore-Clingenpeel; Rodrigo Strehl Machado; Christopher J Nemastil; Sudarshan Jadcherla; Carlo Di Lorenzo; Ajay Kaul; Hayat Mousa
Journal:  Transl Gastroenterol Hepatol       Date:  2019-09-16

9.  Respiratory pathogens adopt a chronic lifestyle in response to bile.

Authors:  F Jerry Reen; David F Woods; Marlies J Mooij; Claire Adams; Fergal O'Gara
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

10.  Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis.

Authors:  Emily Dimango; Patricia Walker; Claire Keating; Maria Berdella; Newell Robinson; Elinor Langfelder-Schwind; Diane Levy; Xinhua Liu
Journal:  BMC Pulm Med       Date:  2014-02-15       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.